-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
[ Chemical Machinery Equipment Network Market Analysis ] According to national* data, the national economy will recover steadily in 2020, and the completion of the main objectives is better than expected.
Among them, the investment in the pharmaceutical manufacturing industry from January to December increased by 28.
4% year-on-year; the capacity utilization rate of the pharmaceutical manufacturing industry was 75.
0%.
Although it was 1.
6% lower than the previous year, under the influence of the epidemic, such a growth rate has fully demonstrated the strong development of the pharmaceutical manufacturing industry.
Chemical machinery and equipment network market analysis chemical machinery and equipmentAmong them, the investment in the pharmaceutical manufacturing industry from January to December increased by 28.
4% year-on-year; the capacity utilization rate of the pharmaceutical manufacturing industry was 75.
0%.
Although it was 1.
6% lower than the previous year, under the influence of the epidemic, such a growth rate has fully demonstrated the strong development of the pharmaceutical manufacturing industry.
Increased investment in the pharmaceutical industry in many places in 2020
Increased investment in the pharmaceutical industry in many places in 2020According to incomplete statistics, as of now, Shandong, Sichuan, Fujian, Hunan, Yunnan, Guizhou, Jilin, Guangdong, Zhejiang and many other provinces and cities have successively announced their economic performance data for the whole year or the first half of 2020.
Judging from the data of these provinces and cities, most provinces and cities have seen growth in fixed assets, and many places have significantly increased their investment in the pharmaceutical manufacturing industry.
Judging from the data of these provinces and cities, most provinces and cities have seen growth in fixed assets, and many places have significantly increased their investment in the pharmaceutical manufacturing industry.
For example, according to the data released by Shanxi Province* on January 22, the total production value of Shanxi in 2020 was 1,765,193 million yuan, an increase of 3.
6% over the previous year at comparable prices.
The annual fixed asset investment also increased by 10.
6%, 7.
7 percentage points faster than the national level.
Among them, industrial investment is the main driving force for the rapid growth of Shanxi's investment.
Shanxi's industrial investment increased by 16.
4% throughout the year.
From an industry perspective, investment in the manufacturing industry increased by 25.
9%, of which investment in the equipment manufacturing industry increased by 13.
2%, investment in the pharmaceutical industry increased by 22.
2%, investment in the new energy automobile manufacturing industry increased by 60.
2%, and investment in the power industry increased by 34.
8%.
6% over the previous year at comparable prices.
The annual fixed asset investment also increased by 10.
6%, 7.
7 percentage points faster than the national level.
Among them, industrial investment is the main driving force for the rapid growth of Shanxi's investment.
Shanxi's industrial investment increased by 16.
4% throughout the year.
From an industry perspective, investment in the manufacturing industry increased by 25.
9%, of which investment in the equipment manufacturing industry increased by 13.
2%, investment in the pharmaceutical industry increased by 22.
2%, investment in the new energy automobile manufacturing industry increased by 60.
2%, and investment in the power industry increased by 34.
8%.
On January 19, relevant departments of Hubei Province also held a press conference to introduce Hubei's economic operation in 2020.
According to reports, in 2020, the recovery of industrial production in Hubei Province will accelerate, and the high-tech manufacturing industry will grow rapidly.
Statistics show that in 2020, the value added of the province's industrial enterprises above designated size will fall by 6.
1% compared with the previous year, and the rate of decline has narrowed by 39.
7 percentage points from the first quarter.
The monthly growth rate has been positive for eight consecutive months.
In 2020, investment in high-tech manufacturing will also fall by 9.
4%, and the rate of decline narrowed by 72.
1 percentage points.
However, investment in the pharmaceutical manufacturing industry, computer and office equipment manufacturing industry increased by 20.
4% and 14.
7% respectively.
According to reports, in 2020, the recovery of industrial production in Hubei Province will accelerate, and the high-tech manufacturing industry will grow rapidly.
Statistics show that in 2020, the value added of the province's industrial enterprises above designated size will fall by 6.
1% compared with the previous year, and the rate of decline has narrowed by 39.
7 percentage points from the first quarter.
The monthly growth rate has been positive for eight consecutive months.
In 2020, investment in high-tech manufacturing will also fall by 9.
4%, and the rate of decline narrowed by 72.
1 percentage points.
However, investment in the pharmaceutical manufacturing industry, computer and office equipment manufacturing industry increased by 20.
4% and 14.
7% respectively.
Industry insiders believe that under special circumstances last year, the development of the pharmaceutical sector was still very eye-catching.
While receiving high attention from the capital market, it also obtained numerous investment opportunities.
At present, the industry is generally optimistic about the development of the pharmaceutical industry and believes that as a rigid demand, the market prospects for medicine will be broader in the context of the acceleration of the aging of the population and the upgrading of consumption.
While receiving high attention from the capital market, it also obtained numerous investment opportunities.
At present, the industry is generally optimistic about the development of the pharmaceutical industry and believes that as a rigid demand, the market prospects for medicine will be broader in the context of the acceleration of the aging of the population and the upgrading of consumption.
The pharmaceutical equipment industry ushered in new opportunities for development
The pharmaceutical equipment industry ushered in new opportunities for the development of pharmaceutical equipment
It is worth noting that in the context of changes in the pattern of the pharmaceutical industry and pharmaceutical companies facing new demands such as capacity upgrades, the industry expects that the domestic pharmaceutical equipment industry will also usher in geometric growth.
However, it is worth noting that pharmaceutical equipment is equipment that facilitates the production of drugs.
The technological level of pharmaceutical equipment determines the level of pharmaceuticals.
Therefore, while facing opportunities, pharmaceutical equipment companies also need to deal with the challenges of transformation and upgrading, continuously strengthen R&D investment, and continue to innovate.
technology.
However, it is worth noting that pharmaceutical equipment is equipment that facilitates the production of drugs.
The technological level of pharmaceutical equipment determines the level of pharmaceuticals.
Therefore, while facing opportunities, pharmaceutical equipment companies also need to deal with the challenges of transformation and upgrading, continuously strengthen R&D investment, and continue to innovate.
technology.
It is understood that with the tightening of GMP requirements, many pharmaceutical companies, in order to ensure the cleanliness and sterility of the pharmaceutical production process, will put high demands on related pharmaceutical equipment, such as gas sterilization filtration equipment, to achieve sterile medicine related Quality requirements.
At present, under new demands and user requirements, relevant equipment manufacturing companies have also begun to explore and develop.
At present, under new demands and user requirements, relevant equipment manufacturing companies have also begun to explore and develop.
For example, an enterprise has made some innovative modular designs for the aseptic canning system in accordance with GMP specifications and aseptic process requirements.
Through modular design, the "black and white partition" is designed so that the filling part is in the A-level laminar flow area under the C-level background, and the BFS process is completed in the same station under the A-level air shower protection, and it is in the clean production area and ordinary production.
Each zone is also equipped with a control screen that can be switched to each other.
In this way, during the production period, no operator is required, which can better ensure that the product is in the process of punching, printing, testing, and packaging, and minimize the pollution sources in the filling room, which is more in line with the requirements of GMP and the production requirements of sterile drugs.
Through modular design, the "black and white partition" is designed so that the filling part is in the A-level laminar flow area under the C-level background, and the BFS process is completed in the same station under the A-level air shower protection, and it is in the clean production area and ordinary production.
Each zone is also equipped with a control screen that can be switched to each other.
In this way, during the production period, no operator is required, which can better ensure that the product is in the process of punching, printing, testing, and packaging, and minimize the pollution sources in the filling room, which is more in line with the requirements of GMP and the production requirements of sterile drugs.
In fact, in recent years, in order to accelerate the transformation and upgrading of many pharmaceutical equipment companies, the investment in research and development expenses has been maintaining a continuous growth trend.
For example, in 2019, Chutian Technology's R&D expenses were 178 million yuan, a year-on-year increase of 23.
54%, and the ratio of R&D investment to operating income was 9.
51% in the same period.
The R&D expenses of Tofflon also increased by 21.
81% year-on-year in 2019, and the annual R&D expenses accounted for 5.
26% of revenue.
Tofflon's research and development expenses will continue to rise in 2020, increasing by 37.
76% year-on-year in the first quarter.
For example, in 2019, Chutian Technology's R&D expenses were 178 million yuan, a year-on-year increase of 23.
54%, and the ratio of R&D investment to operating income was 9.
51% in the same period.
The R&D expenses of Tofflon also increased by 21.
81% year-on-year in 2019, and the annual R&D expenses accounted for 5.
26% of revenue.
Tofflon's research and development expenses will continue to rise in 2020, increasing by 37.
76% year-on-year in the first quarter.
Conclusion
Conclusion In 2021, the industry believes that investment in the pharmaceutical manufacturing industry will continue to grow, and as more fixed investment is added to the pharmaceutical industry to boost the development of the pharmaceutical industry, investment in upstream pharmaceutical equipment will also increase accordingly.
This will help encourage companies including small and medium-sized pharmaceutical equipment companies to increase R&D investment, accelerate industrial transformation and upgrading, and meet the needs of the pharmaceutical industry.
In the future, driven by many favorable pharmaceutical policies, my country's pharmaceutical industry is bound to usher in further development.
At the same time, the development prospects of my country's pharmaceutical equipment industry will also be broader.
This will help encourage companies including small and medium-sized pharmaceutical equipment companies to increase R&D investment, accelerate industrial transformation and upgrading, and meet the needs of the pharmaceutical industry.
In the future, driven by many favorable pharmaceutical policies, my country's pharmaceutical industry is bound to usher in further development.
At the same time, the development prospects of my country's pharmaceutical equipment industry will also be broader.
Original title: The growth of investment in the pharmaceutical manufacturing industry brings new opportunities for the development of the pharmaceutical machinery industry